Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression

被引:276
作者
Belzung, Catherine [1 ]
Lemoine, Mael [2 ]
机构
[1] UFR Sci & Techn, U930, Parc Grandmont,Rue Monge, F-37200 Tours, France
[2] Univ Tours, UFR Med, F-37032 Tours, France
关键词
D O I
10.1186/2045-5380-1-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Animal models of psychiatric disorders are usually discussed with regard to three criteria first elaborated by Willner; face, predictive and construct validity. Here, we draw the history of these concepts and then try to redraw and refine these criteria, using the framework of the diathesis model of depression that has been proposed by several authors. We thus propose a set of five major criteria (with sub-categories for some of them); homological validity (including species validity and strain validity), pathogenic validity) including ontopathogenic validity and triggering validity), mechanistic validity, face validity) including ethological and biomarker validity) and predictive validity) including induction and remission validity). Homological validity requires that an adequate species and strain be chosen: considering species validity, primates will be considered to have a higher score than drosophila, and considering strains, a high stress reactivity in a strain scores higher than a low stress reactivity in another strain. Pathological validity corresponds to the fact that, in order to shape pathological characteristics, the organism has been manipulated both during the developmental period) for example, maternal separation: ontopathogenic validity) and during adulthood) for example, stress: triggering validity). Mechanistic validity corresponds to the fact that the cognitive) for example, cognitive bias) or biological mechanisms) such as dysfunction of the hormonal stress axis regulation) underlying the disorder are identical in both humans and animals. Face validity corresponds to the observable behavioral) ethological validity) or biological) biomarker validity) outcomes: for example anhedonic behavior) ethological validity) or elevated corticosterone) biomarker validity). Finally, predictive validity corresponds to the identity of the relationship between the triggering factor and the outcome) induction validity) and between the effects of the treatments on the two organisms) remission validity). The relevance of this framework is then discussed regarding various animal models of depression.
引用
收藏
页数:14
相关论文
共 50 条
[1]  
Abramson Lyn Y., 1977, PSYCHOPATHOLOGY EXPT, P1
[2]   Dissociated neural representations of intensity and valence in human olfaction [J].
Anderson, AK ;
Christoff, K ;
Stappen, I ;
Panitz, D ;
Ghahremani, DG ;
Glover, G ;
Gabrieli, JDE ;
Sobel, N .
NATURE NEUROSCIENCE, 2003, 6 (02) :196-202
[3]   Olfaction: A potential cognitive marker of psychiatric disorders [J].
Atanasova, Boriana ;
Graux, Jerome ;
El Hage, Wissam ;
Hommet, Caroline ;
Camus, Vincent ;
Belzung, Catherine .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (07) :1315-1325
[4]   Olfactory anhedonia and negative olfactory alliesthesia in depressed patients [J].
Atanasova, Boriana ;
El-Hage, Wissam ;
Chabanet, Claire ;
Gaillard, Philippe ;
Belzung, Catherine ;
Camus, Vincent .
PSYCHIATRY RESEARCH, 2010, 176 (2-3) :190-196
[5]   The design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature [J].
Belzung, Catherine ;
de Villemeur, Etienne Billette .
BEHAVIOURAL PHARMACOLOGY, 2010, 21 (08) :677-689
[6]  
Belzung Catherine, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/59676
[7]   Antidepressants increase neural progenitor cells in the human hippocampus [J].
Boldrini, Maura ;
Underwood, Mark D. ;
Hen, Rene ;
Rosoklija, Gorazd B. ;
Dwork, Andrew J. ;
Mann, J. John ;
Arango, Victoria .
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (11) :2376-2389
[8]  
Campbell D.T., 1963, EXPT QUASIEXPERIMENT
[9]   CONSTRUCT VALIDITY IN PSYCHOLOGICAL TESTS [J].
CRONBACH, LJ ;
MEEHL, PE .
PSYCHOLOGICAL BULLETIN, 1955, 52 (04) :281-302
[10]   Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors [J].
Cryan, JF ;
O'Leary, OF ;
Jin, SH ;
Friedland, JC ;
Ouyang, M ;
Hirsch, BR ;
Page, ME ;
Dalvi, A ;
Thomas, SA ;
Lucki, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (21) :8186-8191